Spectroscopic analyser
AssigneeKlein Medical Limited
InventorsDonal Paul Krouse, Raymond Andrew Simpkin, Bryan James Smith
Life of this patent
Estimating the term…
Loading patent…
AssigneeKlein Medical Limited
InventorsDonal Paul Krouse, Raymond Andrew Simpkin, Bryan James Smith
Estimating the term…
An analyser 10 for identifying or verifying or otherwise characterising a liquid based drug sample 16 comprising: an electromagnetic radiation source 11 for emitting electromagnetic radiation 14a in at least one beam at a sample 16, the electromagnetic radiation comprising at least two different wavelengths, a sample detector 17 that detects affected electromagnetic radiation resulting from the emitted electromagnetic radiation affected by the sample, and a processor 18 for identifying or verifying the sample from the detected affected electromagnetic radiation, wherein each wavelength or at least two of the wavelengths is between substantially 1300 nm and 2000 nm, and each wavelength or at least two of the wavelengths is in the vicinity of the wavelength(s) of (or within a region spanning) a spectral characteristic in the liquid spectrum between substantially 1300 nm and 2000 nm.
An analyser for identifying or verifying a liquid drug for delivery to a patient to reduce risk of adverse drug events, the liquid drug comprising a drug in a base liquid, the liquid drug having a liquid drug spectrum and the base liquid having a base liquid spectrum comprising at least one spectral characteristic feature between substantially 1300 nm and 2000 nm, the analyser comprising:
A method for identifying or verifying a liquid drug for delivery to a patient to reduce risk of adverse drug events, the liquid drug comprising a drug in a base liquid, the liquid drug having a liquid drug spectrum and the base liquid having a base liquid spectrum comprising at least one spectral characteristic feature between substantially 1300 nm and 2000 nm, the method comprising:
Dependencies are inferred from the claim text.